← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ut Southwestern Medical Center
Dallas, TX
$4,031,063,625
Total funding
3,469
Grants
Funding over time
peak $352.7M · FY2006–25$500M$375M$250M$125M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,014,486,411 · 3452
CDC$11,430,448 · 10
AHRQ$7,645,989 · 5
FDA$2,639,036 · 3
By mechanism
R01$2,238,235,667 · 1231
P01$200,183,784 · 146
U01$158,787,338 · 57
R35$158,726,681 · 68
UL1$99,910,405 · 28
T32$99,439,811 · 32
Investigators at Ut Southwestern Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Cell Biology Research Improvements and Renovations$14,954,444
C06 · FY2010 · RR
NIDA Clinical Trials Network: Big South/West Node$10,575,670
UG1 · FY2021 · DA
Targeting EWSR1-FLI1 through Functional, Structural and Chemical Approaches$10,042,149
U54 · FY2019 · CA
NIDA Clinical Trials Network: Big South/West Node$8,888,943
UG1 · FY2023 · DA
UT Southwestern Center for Translational Medicine$8,029,629
UL1 · FY2021 · TR
UT Southwestern Center for Translational Medicine$7,940,539
UL1 · FY2022 · TR
UT Southwestern Center for Translational Medicine$7,932,987
UL1 · FY2024 · TR
UT Southwestern Center for Translational Medicine$7,932,987
UL1 · FY2023 · TR
UT Southwestern Center for Translational Medicine$7,513,496
UL1 · FY2025 · TR
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2021 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2020 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2023 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2019 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2022 · AI
UT-Southwestern Clinical and Translational Alliance for Research (UT-STAR) (TL1)$6,339,719
UL1 · FY2012 · TR
North and Central Texas Clinical and Translational Science Initiative (UL1)$5,933,672
UL1 · FY2011 · RR
NIDA Clinical Trials Network: Big South/West Node$5,809,886
UG1 · FY2024 · DA
North and Central Texas Clinical and Translational Science Initiative (UL1)$5,780,737
UL1 · FY2009 · RR
North and Central Texas Clinical and Translational Science Initiative (UL1)$5,623,159
UL1 · FY2010 · RR
Project-003$5,606,566
UG1 · FY2025 · DA